Ultragenyx Pharma (RARE) PT Lowered to $70 at Wedbush
Tweet
Share
E-mailGet Alerts RARE Hot Sheet
Price: $26.49 +0.42%
Rating Summary:
21 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
21 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Wedbush analyst Laura Chico lowered the price target on Ultragenyx Pharma (NASDAQ: RARE) to $70.00 (from $72.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Tactical Resources completes Plum merger, set for Nasdaq debut
- Petronet LNG Ltd. (PLNG:IN) PT Raised to INR310 at ICICI Securities
- Indigo Paints (INDIGOPN:IN) PT Raised to INR1,300 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
